This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07593/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07593/identifier/pdb/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07593/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07593/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07593/identifier/drugbank/

Statements

Subject Item
n2:DB07593
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB07593 n12:DB07593
dcterms:title
1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE
adms:identifier
n6:8238257 n7:10062714 n8:99444064 n11:DB07593 n13:CT2
n3:IUPAC-Name
n4:271B5371-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5377-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5376-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5373-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5374-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5375-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B536F-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5370-363D-11E5-9242-09173F13E4C5 n4:271B536D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B536E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B537D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B537E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5378-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5379-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B537B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B537A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B537C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5383-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5385-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5386-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5382-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5381-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5384-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5372-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B537F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5380-363D-11E5-9242-09173F13E4C5